J&J Streamlines Some Pharma Functions, Explores Sales Force “Efficiencies”
This article was originally published in The Tan Sheet
Executive Summary
"Sales force efficiencies" being explored at Johnson & Johnson as one component of a cost-cutting plan will not directly affect the firm's consumer divisions
You may also be interested in...
Big Pharma “Cost Structure” Needs Attention, Lilly CEO Says
The pharmaceutical industry needs to make significant changes to its cost structure to remain competitive over the next three to five years, Lilly CEO Sidney Taurel said
Big Pharma “Cost Structure” Needs Attention, Lilly CEO Says
The pharmaceutical industry needs to make significant changes to its cost structure to remain competitive over the next three to five years, Lilly CEO Sidney Taurel said
Bristol Rethinking Sales Model, May Try New Approach To Sampling
Bristol-Myers Squibb is reexamining the role of sales forces to find new ideas for reaching physicians